The North America GMP Cytokines Market is expanding steadily, driven by growing investments in cell and gene therapy, advanced biologics manufacturing, and regenerative medicine. The region benefits from a mature biotechnology ecosystem and stringent quality requirements that encourage the use of GMP-grade cytokines with consistent quality, traceability, and regulatory documentation. The US...